PROS1 and infection: Our research revealed that the administration of ≥2 doses of either an inactivated SARS-CoV-2 virus vaccine or an S protein-based vaccine notably increased the generation of targeted neutralizing antibodies specific to the BA.5 variant, during infection with the strain.